BamSEC and AlphaSense Join Forces
Learn More

Ariad Pharmaceuticals Inc

Formerly NASDAQ: ARIA
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.2
from 10-Q/A 58 pages Share Purchase Agreement by and Among Incyte Europe S.À R.L., Ariad Pharmaceuticals (Cayman) L.P., Ariad Pharmaceuticals, Inc. (As Guarantor), and Incyte Corporation
12/34/56
EX-10.1
from 10-Q/A 100 pages Amended and Restated Buy-In License Agreement Between Ariad Pharmaceuticals, Inc. and Ariad Pharmaceuticals (Europe) Sarl and Incyte Corporation
12/34/56
EX-10.1
from 8-K 5 pages Call Option and Warrant Termination Agreement
12/34/56
EX-10.3
from 8-K 15 pages Executive Employment Agreement
12/34/56
EX-10.2
from 8-K 15 pages Executive Employment Agreement
12/34/56
EX-10.1
from 8-K 15 pages Executive Employment Agreement
12/34/56
EX-10.1
from 10-Q 15 pages Executive Employment Agreement
12/34/56
EX-10.9
from 10-Q 2 pages Ariad Pharmaceuticals, Inc. 2014 Long-Term Incentive Plan Form of Performance Share Agreement
12/34/56
EX-10.8
from 10-Q 2 pages Ariad Pharmaceuticals, Inc. 2014 Long-Term Incentive Plan Form of Restricted Stock Unit Agreement
12/34/56
EX-10.7
from 10-Q 2 pages Ariad Pharmaceuticals, Inc. 2014 Long-Term Incentive Plan Form of Option Agreement
12/34/56
EX-10.6
from 10-Q 15 pages Executive Employment Agreement
12/34/56
EX-10.5
from 10-Q 15 pages Executive Employment Agreement
12/34/56
EX-10.4
from 10-Q 9 pages Partial Release of Security Interest
12/34/56
EX-10.3
from 10-Q 7 pages Amendment No. 1 to Riaa
12/34/56
EX-10.2
from 10-Q 58 pages Share Purchase Agreement by and Among Incyte Europe S.À R.L., Ariad Pharmaceuticals (Cayman) L.P., Ariad Pharmaceuticals, Inc. (As Guarantor), and Incyte Corporation (As Guarantor) May 9, 2016 Portions of This Exhibit, Indicated by the Mark “[***],” Were Omitted and Have Been Filed Separately With the Securities and Exchange Commission Pursuant to the Registrant’s Application Requesting Confidential Treatment Pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as Amended
12/34/56
EX-10.1
from 10-Q 101 pages Amended and Restated Buy-In License Agreement Between Ariad Pharmaceuticals, Inc. and Ariad Pharmaceuticals (Europe) Sarl and Incyte Corporation
12/34/56
EX-10.15
from 10-K/A 28 pages Executive Employment Agreement
12/34/56
EX-10.1
from 8-K 4 pages Amendment to Agreement
12/34/56
EX-10.3
from 8-K 2 pages Form of Stock Option Agreement Governed by the Terms, Conditions and Limitations of the Ariad Pharmaceuticals, Inc. 2014 Long-Term Incentive Plan
12/34/56
EX-10.2
from 8-K 2 pages Form of Restricted Stock Unit Agreement Governed by the Terms, Conditions and Limitations of the Ariad Pharmaceuticals, Inc. 2014 Long-Term Incentive Plan
12/34/56